BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30060262)

  • 1. Molecular Signatures of Lithium Treatment: Current Knowledge.
    Bellivier F; Marie-Claire C
    Pharmacopsychiatry; 2018 Sep; 51(5):212-219. PubMed ID: 30060262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium response viewed as a biomarker to predict developmental psychopathology in offspring with bipolar disorder: a commentary.
    Pavuluri MN; Lee MS; Pandey G
    Bipolar Disord; 2015 Mar; 17(2):224-32. PubMed ID: 25523965
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding.
    Malhi GS; Outhred T
    CNS Drugs; 2016 Oct; 30(10):931-49. PubMed ID: 27638546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relationship Between Lithium and Cancer Proliferation: A Case-Based Review of the Literature.
    Ozerdem A; Ceylan D; Targıtay B
    Curr Drug Metab; 2018; 19(8):653-662. PubMed ID: 29708074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium reverses behavioral and axonal transport-related changes associated with ANK3 bipolar disorder gene disruption.
    Gottschalk MG; Leussis MP; Ruland T; Gjeluci K; Petryshen TL; Bahn S
    Eur Neuropsychopharmacol; 2017 Mar; 27(3):274-288. PubMed ID: 28109561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and clinical factors predict lithium's effects on PER2 gene expression rhythms in cells from bipolar disorder patients.
    McCarthy MJ; Wei H; Marnoy Z; Darvish RM; McPhie DL; Cohen BM; Welsh DK
    Transl Psychiatry; 2013 Oct; 3(10):e318. PubMed ID: 24150227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of Lithium Response in Bipolar Disorder.
    Papiol S; Schulze TG; Alda M
    Pharmacopsychiatry; 2018 Sep; 51(5):206-211. PubMed ID: 29579760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PtdIns(3,4,5)P(3) and inositol depletion as a cellular target of mood stabilizers.
    Teo R; King J; Dalton E; Ryves J; Williams RS; Harwood AJ
    Biochem Soc Trans; 2009 Oct; 37(Pt 5):1110-4. PubMed ID: 19754462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of lithium effects on glomerular function in bipolar disorder patients under chronic lithium treatment: a pilot study.
    Tsermpini EE; Zhang Y; Niola P; Chillotti C; Ardau R; Bocchetta A; Patrinos GP; Del Zompo M; Severino G; Lee MT; Squassina A
    Neurosci Lett; 2017 Jan; 638():1-4. PubMed ID: 27923663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients.
    Tondo L; Baldessarini RJ
    Epidemiol Psichiatr Soc; 2009; 18(3):179-83. PubMed ID: 20034193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of brain barriers in the neurokinetics and pharmacodynamics of lithium.
    Luo H; Chevillard L; Bellivier F; Mégarbane B; Etain B; Cisternino S; Declèves X
    Pharmacol Res; 2021 Apr; 166():105480. PubMed ID: 33549730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics.
    Alda M
    Mol Psychiatry; 2015 Jun; 20(6):661-70. PubMed ID: 25687772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium and Therapeutic Targeting of GSK-3.
    Snitow ME; Bhansali RS; Klein PS
    Cells; 2021 Jan; 10(2):. PubMed ID: 33525562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased mRNA expression of peripheral glial cell markers in bipolar disorder: The effect of long-term lithium treatment.
    Ferensztajn-Rochowiak E; Tarnowski M; Samochowiec J; Michalak M; Ratajczak MZ; Rybakowski JK
    Eur Neuropsychopharmacol; 2016 Sep; 26(9):1516-1521. PubMed ID: 27474686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recurrence following discontinuation of 28 years of lithium therapy].
    Wegmann SD; Kessing LV
    Ugeskr Laeger; 2011 Mar; 173(11):820-1. PubMed ID: 21402017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to lithium has a neurobiological signature.
    Caye A; Passos IC; Kunz M; Kauer-Sant'anna M
    Mol Psychiatry; 2020 Mar; 25(3):509-510. PubMed ID: 29691466
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The science and practice of lithium therapy.
    Malhi GS; Tanious M; Das P; Berk M
    Aust N Z J Psychiatry; 2012 Mar; 46(3):192-211. PubMed ID: 22391277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response.
    Hajek T; Bauer M; Simhandl C; Rybakowski J; O'Donovan C; Pfennig A; König B; Suwalska A; Yucel K; Uher R; Young LT; MacQueen G; Alda M
    Psychol Med; 2014 Feb; 44(3):507-17. PubMed ID: 23721695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited.
    Harwood AJ
    Mol Psychiatry; 2005 Jan; 10(1):117-26. PubMed ID: 15558078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.